109 related articles for article (PubMed ID: 10102466)
21. Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant.
Sailer T; Vormittag R; Koder S; Quehenberger P; Kaider A; Pabinger I
Thromb Res; 2008; 122(2):153-60. PubMed ID: 18031797
[TBL] [Abstract][Full Text] [Related]
22. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
Sailer T; Vormittag R; Zoghlami C; Koder S; Quehenberger P; Male C; Pabinger I
Thromb Res; 2007; 120(2):295-302. PubMed ID: 17328943
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
[TBL] [Abstract][Full Text] [Related]
25. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
Exner T; Low J
Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
[TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
[TBL] [Abstract][Full Text] [Related]
27. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
28. An automated chromogenic peptide substrate assay for coagulation factor XII.
Jones DW; Gallimore MJ; Winter M
Blood Coagul Fibrinolysis; 1998 Mar; 9(2):183-7. PubMed ID: 9622217
[TBL] [Abstract][Full Text] [Related]
29. [Preliminary study on the effects of coagulation factor XII on fibrinolysis].
Hu Y; Wang H; Jiao J; Wang Y; Yu W; Ling X
Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):466-8. PubMed ID: 11877020
[TBL] [Abstract][Full Text] [Related]
30. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
31. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
32. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
[TBL] [Abstract][Full Text] [Related]
33. The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome.
Harris SL; Jones DW; Gallimore MJ; Nicholls PJ; Winter M
J Thromb Haemost; 2005 May; 3(5):969-75. PubMed ID: 15869593
[TBL] [Abstract][Full Text] [Related]
34. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Mitu AC; Iliescu I; Dumitrescu L; Pavel I; Silosi I
Rom J Intern Med; 2008; 46(4):337-41. PubMed ID: 19480300
[TBL] [Abstract][Full Text] [Related]
35. Factor XII Shizuoka, a novel mutation (Ala392Thr) identified and characterized in a patient with congenital coagulation factor XII deficiency.
Oguchi S; Ishii K; Moriki T; Takeshita E; Murata M; Ikeda Y; Watanabe K
Thromb Res; 2005; 115(3):191-7. PubMed ID: 15617741
[TBL] [Abstract][Full Text] [Related]
36. Factor XII does not initiate prekallikrein activation on endothelial cells.
Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
[TBL] [Abstract][Full Text] [Related]
37. Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin.
Rao LV; Hoang AD; Rapaport SI
Thromb Haemost; 1995 Apr; 73(4):668-74. PubMed ID: 7495076
[TBL] [Abstract][Full Text] [Related]
38. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.
Baca V; Montiel G; Meillón L; Pizzuto J; Catalán T; Juan-Shum L; Nieva B
Am J Hematol; 2002 Nov; 71(3):200-7. PubMed ID: 12410576
[TBL] [Abstract][Full Text] [Related]
40. Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies.
Le Querrec A; Arnout J; Arnoux D; Borg JY; Caron C; Darnige L; Delahousse B; Reber G; Sié P
Thromb Haemost; 2001 Aug; 86(2):584-9. PubMed ID: 11522007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
